These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 1314381)

  • 1. V beta 17 T-cell deletion by endogenous mammary tumor virus in wild-type-derived mouse strain.
    Jouvin-Marche E; Cazenave PA; Voegtle D; Marche PN
    Proc Natl Acad Sci U S A; 1992 Apr; 89(8):3232-5. PubMed ID: 1314381
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mls-1 is encoded by the long terminal repeat open reading frame of the mouse mammary tumor provirus Mtv-7.
    Beutner U; Frankel WN; Cote MS; Coffin JM; Huber BT
    Proc Natl Acad Sci U S A; 1992 Jun; 89(12):5432-6. PubMed ID: 1319061
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The use of mammary tumor virus (Mtv)-negative and single-Mtv mice to evaluate the effects of endogenous viral superantigens on the T cell repertoire.
    Scherer MT; Ignatowicz L; Pullen A; Kappler J; Marrack P
    J Exp Med; 1995 Nov; 182(5):1493-504. PubMed ID: 7595219
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A novel V beta 2-specific endogenous mouse mammary tumor virus which is capable of producing a milk-borne exogenous virus.
    Niimi N; Wajjwalku W; Ando Y; Nakamura N; Ueda M; Yoshikai Y
    J Virol; 1995 Nov; 69(11):7269-73. PubMed ID: 7474151
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of an endogenous mammary tumor virus involved in the clonal deletion of V beta 2 T cells.
    Jouvin-Marche E; Marche PN; Six A; Liebe-Gris C; Voegtle D; Cazenave PA
    Eur J Immunol; 1993 Nov; 23(11):2758-64. PubMed ID: 8223851
    [TBL] [Abstract][Full Text] [Related]  

  • 6. T cell receptor V beta repertoire in mice lacking endogenous mouse mammary tumor provirus.
    Braun MY; Jouvin-Marche E; Marche PN; MacDonald HR; Acha-Orbea H
    Eur J Immunol; 1995 Mar; 25(3):857-62. PubMed ID: 7705418
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An exogenous mouse mammary tumor virus with properties of Mls-1a (Mtv-7).
    Held W; Shakhov AN; Waanders G; Scarpellino L; Luethy R; Kraehenbuhl JP; MacDonald HR; Acha-Orbea H
    J Exp Med; 1992 Jun; 175(6):1623-33. PubMed ID: 1316932
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The open reading frames in the 3' long terminal repeats of several mouse mammary tumor virus integrants encode V beta 3-specific superantigens.
    Pullen AM; Choi Y; Kushnir E; Kappler J; Marrack P
    J Exp Med; 1992 Jan; 175(1):41-7. PubMed ID: 1309854
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of mouse mammary tumor virus-induced T cell responses in vivo by antibodies to an open reading frame protein.
    Acha-Orbea H; Scarpellino L; Shakhov AN; Held W; MacDonald HR
    J Exp Med; 1992 Dec; 176(6):1769-72. PubMed ID: 1334118
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mls-1-like superantigen in the MA/MyJ mouse is encoded by a new mammary tumor provirus that is distinct from Mtv-7.
    Rudy CK; Kraus E; Palmer E; Huber BT
    J Exp Med; 1992 Jun; 175(6):1613-21. PubMed ID: 1316931
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tissue distribution of Mtv-7-like exogenous retroviral transcripts and clonal deletion of V beta 6+ T cells in Mls-1b BALB/c mice.
    Desaymard C; Tucek CL; Rocha B; Korman AJ; Papiernik M
    Int Immunol; 1993 Feb; 5(2):217-22. PubMed ID: 8383996
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rat T cell responses to superantigens. II. Allelic differences in V beta 8.2 and V beta 8.5 beta chains determine responsiveness to staphylococcal enterotoxin B and mouse mammary tumor virus-encoded products.
    Gold DP; Surh CD; Sellins KS; Schroder K; Sprent J; Wilson DB
    J Exp Med; 1994 Jan; 179(1):63-9. PubMed ID: 8270884
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A V beta 8.2-specific superantigen from exogenous mouse mammary tumor virus carried by FM mice.
    Yoshimoto T; Nagase H; Nakano H; Matsuzawa A; Nariuchi H
    Eur J Immunol; 1994 Jul; 24(7):1612-9. PubMed ID: 7913038
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Delay in expression of a mammary tumor provirus is responsible for defective clonal deletion during postnatal period.
    Niimi N; Wajjwalku W; Ando Y; Tomida S; Takeuchi M; Ueda M; Kaneda T; Yoshikai Y
    Eur J Immunol; 1994 Feb; 24(2):488-91. PubMed ID: 8299700
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Divergent viral superantigens delete V beta 5+ T lymphocytes.
    Gollob KJ; Palmer E
    Proc Natl Acad Sci U S A; 1992 Jun; 89(11):5138-41. PubMed ID: 1317583
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of two structurally identical viral superantigens results in thymic elimination at distinct developmental stages.
    Morishima C; Norby-Slycord C; McConnell KR; Finch RJ; Nelson AJ; Farr AG; Pullen AM
    J Immunol; 1994 Dec; 153(11):5091-103. PubMed ID: 7963568
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Peripheral T cell activation and deletion induced by transfer of lymphocyte subsets expressing endogenous or exogenous mouse mammary tumor virus.
    Waanders GA; Shakhov AN; Held W; Karapetian O; Acha-Orbea H; MacDonald HR
    J Exp Med; 1993 May; 177(5):1359-66. PubMed ID: 8386743
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of the Mlsf system. II. Identification of mouse mammary tumor virus proviruses involved in the clonal deletion of self-Mlsf-reactive T cells.
    Foo-Phillips M; Kozak CA; Principato MA; Abe R
    J Immunol; 1992 Dec; 149(11):3440-7. PubMed ID: 1331236
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Susceptibility to tumors induced by polyoma virus is conferred by an endogenous mouse mammary tumor virus superantigen.
    Lukacher AE; Ma Y; Carroll JP; Abromson-Leeman SR; Laning JC; Dorf ME; Benjamin TL
    J Exp Med; 1995 May; 181(5):1683-92. PubMed ID: 7722447
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of key amino acids of the mouse mammary tumor virus superantigen involved in the specific interaction with T-cell receptor V(beta) domains.
    Baribaud F; Wirth S; Maillard I; Valsesia S; Acha-Orbea H; Diggelmann H
    J Virol; 2001 Aug; 75(16):7453-61. PubMed ID: 11462017
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.